Palisade Bio (PALI) EBIT Margin (QoQ) (2011 - 2020)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -5.72 Mn |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | -4.06 Mn |
| Mar 31, 2020 | 5.22 Mn |
| Dec 31, 2019 | -33,592.00 |
| Sep 30, 2019 | -6.07 Mn |
| Jun 30, 2019 | 7.40 Mn |
| Mar 31, 2019 | -2.61 Mn |
| Dec 31, 2018 | 1.11 Mn |
| Sep 30, 2018 | -8.25 Mn |
| Jun 30, 2018 | 9.32 Mn |
| Mar 31, 2018 | -9.31 Mn |
| Dec 31, 2017 | 10.26 Mn |
| Sep 30, 2017 | 6.52 Mn |
| Jun 30, 2017 | 55,104.00 |
| Mar 31, 2017 | -10.47 Mn |
| Dec 31, 2016 | 13.21 Mn |
| Sep 30, 2016 | -4.33 Mn |
| Jun 30, 2016 | 9.60 Mn |
| Mar 31, 2016 | -7.53 Mn |
| Dec 31, 2015 | 3.38 Mn |
| Sep 30, 2015 | -811,192.00 |
| Jun 30, 2015 | -4.16 Mn |
| Mar 31, 2015 | -5.87 Mn |
| Dec 31, 2014 | -1.73 Mn |
| Sep 30, 2014 | -1.19 Mn |
| Jun 30, 2014 | 5.40 Mn |
| Mar 31, 2014 | -1.37 Mn |
| Dec 31, 2013 | 3.49 Mn |
| Sep 30, 2013 | -1.59 Mn |
| Jun 30, 2013 | -12.66 Mn |
| Mar 31, 2013 | 10.63 Mn |
| Dec 31, 2012 | -10.76 Mn |
| Sep 30, 2012 | 153,847.00 |
| Jun 30, 2012 | -147,411.00 |
| Mar 31, 2012 | -68,441.00 |
| Dec 31, 2011 | 222,453.00 |